Aortic Stenosis Treatment Market Outlook:
Aortic Stenosis Treatment Market size was valued at approximately USD 9.42 billion in 2025 and is projected to reach around USD 25 billion by the end of 2035, rising at a CAGR of approximately 10.3% during the forecast period 2026-2035. In 2026, the industry size of the aortic stenosis treatment is evaluated at USD 24.6 billion.
The research and development in aortic stenosis treatment is promptly upgrading with utmost focus on upgrading transcatheter aortic valve replacement devices. Prominent companies such as Medtronic and Edwards are altering the designs of the valves to have a low-profile system for delivery. Research efforts are also being made in the embolic protection devices with AI-enabled planning and computational modelling to enhance the safety and outcomes. Healthcare providers are giving tailored treatment, which is shaping the market with long-lasting management. The advances in material science are reshaping the methods of how aortic stenosis is treated globally.
The supply chain of the market is highly regulated and involves numerous stakeholders from sourcing the raw materials to delivery to the patient. The procurement of the raw material starts with special materials such as medical-grade metals and animal tissues from pigs or cows. Market players such as Lifesciences and Abbott use these materials to fabricate catheters. The supply chain plays a prominent role in the smooth growth of the market, and companies are putting in efforts to lead a well-organized downstream supply chain.
